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The Brazilian System of Science and Technology has launched 
the National Institutes for Science and Technology which are 
intended as nation-wide networks of research. This initiative has 
been coordinated by the Ministry of Science and Technology and 
the Conselho Nacional de Desenvolvimento Científico e Tecnoló-
gico (CNPq); the Institutes were officially launched in November 
2008. The budget for this initiative is about US$260 million over 
the next five years. The Institutes will occupy a strategic position 
in the country and will be run in partnership with six State-run 
foundations for research support, in a joint effort with the Ministry 
of Health and Education, Coordenação de Aperfeiçoamento de 
Pessoal de Nível Superior (CAPES), Petrobras, and the National 
Bank for Social and Economic Development (BNDES).
The INCT for Translational Medicine represents perhaps a unique 
opportunity in the field of health-related research, since it offers a 
potential means of applying the findings obtained in basic research 
to everyday healthcare. The group awarded with the INCT-TM has 
become accustomed to the concept of translational research in its 
efforts to apply the advances made in the field of growth factors 
research to applications in psychiatry and neurology. In fact, the 
free enterprise sector has been faster than the Academia in using 
translational research to boost the development of products and 
patents. In this particular field, the Brazilian structure for research 
development is rather poor: while 2% of the science produced in 
the world comes from Brazil, only 0.1% of the total patents are 
filed by Brazilian researchers, a 20-fold gap. The INCT-TM has been 
designed to fill this gap within the area of health-related research. 
It was conceived as the collaborative effort of six centers: UFRGS, 
USP-RP, UFRJ, PUC-RS, UNESC and a core facility in which over 
70 researchers and 150 students participate directly. The INCT-TM 
also has a wide interaction with several Brazilian and international 
research groups from different countries such as Canada, the UK, 
the USA and Spain. 
Thus, we expect that the results of the ongoing and future studies 
of the INCT-TM will help Brazilian science to develop a translational 
edge, with greater attention paid to the potential benefits of using 
new findings from basic science as a means to achieve more 
effective healthcare.
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